Comparison tool
Calcitonin vs Oxytocin side-by-side
Stack up to four peptides by evidence status, mechanisms, study dosing, side effects, and references.
Comparison tool
Stack up to four peptides by evidence status, mechanisms, study dosing, side effects, and references.
Selected (2/4)
Share this peptide comparison
| Property | Calcitonin | Oxytocin |
|---|---|---|
| Category | Hormonal | Hormonal |
| Also known as | Miacalcin, Fortical, Salmon Calcitonin | Pitocin, Syntocinon, The Love Hormone |
| FDA approved | Yes | Yes |
| Clinical status | FDA Approved - Osteoporosis and Paget's disease
| FDA approved for labor and postpartum use; other uses remain under research
|
| What to expect | Osteoporosis, bone pain, Paget's disease | Social bonding, anxiety, trust, emotional wellbeing |
| How it works | Calcitonin acts through the calcitonin receptor, a G-protein-coupled receptor noted in the source on osteoclasts. Activation of this pathway reduces osteoclast-mediated bone resorption, lowering calcium movement from bone into blood. The source also describes a renal effect that increases calcium loss in urine, so the overall pharmacologic direction is toward lower serum calcium. | Oxytocin acts through the oxytocin receptor, a G-protein-coupled receptor described in the source as present in the uterus, breast tissue, and multiple brain areas including the amygdala. In peripheral tissues, signaling is linked to calcium-mediated uterine contraction and milk ejection. Central effects are described as modulation of fear, reward, and social-attention circuitry, but intranasal research is difficult to interpret because the amount reaching the brain is uncertain and may involve indirect pathways. |
| Typical dosing | Limited community data available · See research protocols | 10-24 IU intranasal as needed · As needed · Intranasal |
| Research dosing | 200 IU intranasal daily · Long-term for osteoporosis · Intranasal spray or injection | 10-40 IU IV for labor · Single dose or short-term use · IV (obstetric); intranasal (research) |
| Typical duration | Long-term for osteoporosis | Single dose or short-term use |
| Administration | Intranasal spray or injection | IV in obstetric labeling; intranasal in research contexts |
| Timing | Morning or as directed With or without food | As needed in studied social or bonding contexts With or without food |
| Evidence level | FDA Approved | FDA Approved |
| Possible side effects |
+4 more
|
+4 more
|
| Research summary | The source presents calcitonin as an established FDA-approved hormone with a narrower modern role in osteoporosis than it once had. It reports utility in hypercalcemia and Paget's disease, while describing weaker osteoporosis fracture-prevention support and a 2013 FDA meta-analysis in salmon calcitonin trials that found a small cancer imbalance versus placebo. The same evidence summary notes that osteoporosis labeling for nasal spray was narrowed to patients unable to use preferred alternatives, and it mentions short-term analgesic interest for acute vertebral fracture pain. | The source treats injectable obstetric oxytocin as established, while describing intranasal behavioral research as contested. For social reward, a 2023 systematic review covering 19 randomized, double-blind, placebo-controlled studies and about 984 participants reported a clearer signal in brain-activity outcomes than in behavior or self-report. In autism research, the source cites a 2021 Scientific Reports randomized trial that did not find a substantial empathy-related neural activation change, and it notes that repeated-dose studies have ranged from modest social-behavior findings to no clear effect. Context and sex-specific differences are presented as important reasons the findings remain difficult to generalize. Short-term intranasal trial safety was described as reassuring, but the source does not establish a reliable clinical benefit for these investigational uses. |
| References | ||
| Full profile | View Details | View Details |
Save this comparison
Keep this research set handy with a free PeptiGuide account.
Save this comparison - free accountTrack your peptide journey
Turn research into a private protocol log when you are ready.
Track your peptide journeyEducational use only. This information is aggregated from public research and community reports. It is not medical advice, and dosing details are descriptive, not recommendations. Always consult a qualified healthcare professional.